Completed
For many living with mental illnesses, current pharmacological interventions are ineffective at delivering adequate relief from disabling symptoms. This virtual public workshop, hosted by the National Academies Forum on Neuroscience and Nervous System Disorders in March 2021, brought together experts and key stakeholders to explore novel molecular targets in the neuropharmacology of mood disorders and psychosis.
The August 2021 National Academies Press publication, Novel Molecular Targets for Mood Disorders and Psychosis - Proceedings of a Workshop summarizes the presentations and discussions from the workshop and is available here.
Featured publication
Novel Molecular Targets for Mood Disorders and Psychosis: Proceedings of a Workshop
Proceedings
·2021
Mood disorders - including depression and bipolar disorder - are common, disabling, and potentially lethal disorders, characterized by a shortened lifespan from comorbid medical illness and rising suicide rates. Medications for these conditions have been shown to be insufficiently effective in the m...
View details